Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Develi Devlet Hastanesi (1)

Hospital Avicenne (1)

USWM, LLC (dba US WorldMeds) (1)

Collaborator

Intervention

apokyn (1)

bupivacaine hcl 0.5% inj 0.75 ml (1)

bupivacaine hcl 0.5% inj 1.5 ml (1)

l-dopa (1)

lidocaine 2% injectable solution 0.75 ml (1)

lidocaine 2% injectable solution 1.5 ml (1)

trimethobenzamide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

Akinesia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Movement Disorders Analysis Using a Deep Learning Approach

Completed

Bradykinesia
+5 more

Bobigny, Seine Saint Denis, France

Hospital Avicenne

Jul 13, 2021

Duration of Anesthesia and Patient Satisfaction After

Unknown status

Cataract Surgery
+5 more

Lidocaine 2% Injectable Solution 0.75 ml
+3 more

Develi, Kayseri, Turkey

Develi Hatice Muammer Kocatürk Devlet Hastanesi

Nov 23, 2019

Parkinson's Disease, Motor Symptoms, Akinesia Trial in United States (APOKYN, L-dopa, Trimethobenzamide)

Completed

Has Results

Parkinson's Disease
+4 more

APOKYN
+2 more

Los Angeles, California
+11 more

Oct 24, 2017